IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 96

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: USE OF ARTIFICIAL INTELLIGENCE IN NOVEL DISSOLUTION ENHANCEMENT TECHNIQUES
Authors Name: AKSHAY BABAN JADHAV , Indrajeet D. Gonjari , Pranita K. More , Divya B. Jagdale , Shreevidya M. Yamatkar
Download E-Certificate: Download
Author Reg. ID:
IJNRD_214108
Published Paper Id: IJNRD2402255
Published In: Volume 9 Issue 2, February-2024
DOI:
Abstract: Intelligent modelling, which aids in knowledge conception, problem solving, and decision making, is the aim of artificial intelligence (AI). The first studies of what is now called artificial intelligence (AI) were carried out in 1943 by Walter Pits and Warren McCulloch. It used to be believed that artificial intelligence (AI) was only used in engineering. However, artificial intelligence (AI) is now widely applied in the pharmacy sector across a wide range of areas, including hospital pharmacy, drug discovery, formulation development for drug delivery, marketing, management, and marketing. Artificial neural network (ANN) techniques are widely used in pharmaceutical research for data filtering and experimental outcome prediction. Regression analysis and a backpropagation network were used in this work to model a new dissolution outcome prediction and screen system. Drug research and the development of drug delivery formulations involve a large number of Artificial Neural Networks (ANNs), including Deep Neural Networks (DNNs) and Recurrent Neural Networks (RNNs). The technology's promise in quantitative structure-property relationship (QSPR) or quantitative structure-activity relationship (QSAR) has been validated, and several drug discovery implementations have been studied. De novo design also promotes the creation of pharmacological compounds with significantly novel properties in terms of intended or ideal attributes. Robots are used by doctors nowadays for a range of medical procedures since they are more dependable than people, have more sophisticated work features, and can finish any task swiftly and effectively. We draw the conclusion that artificial intelligence (AI) is the burgeoning subject that is affecting every business, including pharmacy, and that more work must be done in this area in order to advance the state of the art and carry out fresh investigations. Because of the way the input data was prepared, the relevant data could still be used to train the ANN model even after the formulation composition was changed. This system uses the reference line regression methodology (RLRM) and the effective data regression method (EDRM) to predict dissolution results with a high accuracy rate. Nevertheless, compared to the orthogonal experiment, it requires a smaller database. Additionally, this system implements a decision tree-based data screen function. The drug prediction system created by this artificial neural network (ANN) model is distinct.
Keywords: Artificial Intelligence, Artificial Neural Networks (ANNs), Dissolution Techniques, Theories of Dissolution, Long Short-Term Memory Networks (LSTMs), EDRM, RLRM
Cite Article: "USE OF ARTIFICIAL INTELLIGENCE IN NOVEL DISSOLUTION ENHANCEMENT TECHNIQUES", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 2, page no.c487-c500, February-2024, Available :http://www.ijnrd.org/papers/IJNRD2402255.pdf
Downloads: 000118774
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2402255
Registration ID: 214108
Published In: Volume 9 Issue 2, February-2024
DOI (Digital Object Identifier):
Page No: c487-c500
Country: Satara, Maharashtra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2402255
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2402255
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD